Literature DB >> 19620957

An in vitro FluoroBlok tumor invasion assay.

Jeff Partridge1, Paula Flaherty.   

Abstract

The hallmark of metastatic cells is their ability to invade through the basement membrane and migrate to other parts of the body. Cells must be able to both secrete proteases that break down the basement membrane as well as migrate in order to be invasive. BD BioCoat Tumor Invasion System provides cells with conditions that allow assessment of their invasive property in vitro(1,2). It consists of a BD Falcon FluoroBlok 24-Multiwell Insert Plate with an 8.0 micron pore size PET membrane that has been uniformly coated with BD Matrigel Matrix. This uniform layer of BD Matrigel Matrix serves as a reconstituted basement membrane in vitro providing a true barrier to non-invasive cells while presenting an appropriate protein structure to study invasion. The coating process occludes the pores of the membrane, blocking non-invasive cells from migrating through the membrane. In contrast, invasive cells are able to detach themselves from and migrate through the coated membrane. Quantitation of cell invasion can be achieved by either pre- or post-cell invasion labeling with a fluorescent dye such as DiIC(12;)(3) or calcein AM, respectively, and measuring the fluorescence of invading cells. Since the BD FluoroBlok membrane effectively blocks the passage of light from 490-700 nm at >99% efficiency, fluorescently-labeled cells that have not invaded are not detected by a bottom-reading fluorescence plate reader. However, cells that have invaded to the underside of the membrane are no longer shielded from the light source and are detected with the respective plate reader. This video demonstrates an endpoint cell invasion assay, using calcein AM to detect invaded cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620957      PMCID: PMC3148933          DOI: 10.3791/1475

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  4 in total

1.  Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.

Authors:  Gautam Sethi; Kwang Seok Ahn; Manoj K Pandey; Bharat B Aggarwal
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

2.  Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion.

Authors:  Asha S Nair; Shishir Shishodia; Kwang Seok Ahn; Ajaikumar B Kunnumakkara; Gautam Sethi; Bharat B Aggarwal
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

3.  Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.

Authors:  Yasunari Takada; Yoshinori Kobayashi; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

4.  Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Kwang S Ahn; Preetha Anand; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

  4 in total
  15 in total

1.  UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

Authors:  Yanhong Luo; Jianfeng He; Chunlin Yang; Matthew Orange; Xingcong Ren; Nick Blair; Tao Tan; Jin-Ming Yang; Hua Zhu
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

2.  Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.

Authors:  Kristina Cotter; Joseph Capecci; Souad Sennoune; Markus Huss; Martin Maier; Raul Martinez-Zaguilan; Michael Forgac
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

3.  Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells.

Authors:  Hui Zhang; Jian Gong; Di Kong; Hong-Yi Liu
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

Review 4.  Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae.

Authors:  Zhenjia Wang; Chinnaswamy Tiruppathi; Jaehyung Cho; Richard D Minshall; Asrar B Malik
Journal:  IUBMB Life       Date:  2011-07-15       Impact factor: 3.885

5.  The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells.

Authors:  Joseph Capecci; Michael Forgac
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

Review 6.  Reviewing and reconsidering invasion assays in head and neck cancer.

Authors:  Ronald C Inglehart; Christina S Scanlon; Nisha J D'Silva
Journal:  Oral Oncol       Date:  2014-10-14       Impact factor: 5.337

7.  The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.

Authors:  Jin Qiu; Pamela Smith; Leah Leahy; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2015-01-15       Impact factor: 6.823

8.  Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the Accuracy.

Authors:  Heidi Marie Stoellinger; Arshak R Alexanian
Journal:  Assay Drug Dev Technol       Date:  2022-02-23       Impact factor: 1.738

9.  Ozone Exposure During Implantation Increases Serum Bioactivity in HTR-8/SVneo Trophoblasts.

Authors:  Colette N Miller; Erica J Stewart; Samantha J Snow; Wanda C Williams; Judy H Richards; Leslie C Thompson; Mette C Schladweiler; Aimen K Farraj; Urmila P Kodavanti; Janice A Dye
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

10.  Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.

Authors:  David S Guttery; Rachael A Hancox; Kellie T Mulligan; Simon Hughes; Sinead M Lambe; J Howard Pringle; Rosemary A Walker; J Louise Jones; Jacqueline A Shaw
Journal:  Breast Cancer Res       Date:  2010-08-02       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.